Literature DB >> 21916635

"Pay for delay" settlements of disputes over pharmaceutical patents.

Aaron S Kesselheim1, Lindsey Murtagh, Michelle M Mello.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21916635     DOI: 10.1056/NEJMhle1102235

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

Authors:  Aaron S Kesselheim
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

2.  Are reverse payments and pay-for-delay settlements business as usual or an anticompetitive practice?

Authors:  Swati Shah; Matthew A Silva; Michael J Malloy
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

Review 3.  FDA Policy and Cardiovascular Medicine.

Authors:  Joseph S Ross; Aaron S Kesselheim
Journal:  Circulation       Date:  2015-09-22       Impact factor: 29.690

4.  Rising health care costs and life-cycle management in the pharmaceutical market.

Authors:  Aaron S Kesselheim
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.